ArticleOncoTargets and therapy2022
Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study [Retraction].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.